Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006

OBJECTIVE: Patients with melanoma and early stable disease (SD) with pembrolizumab have unclear prognosis. We present post hoc analyses of long-term outcomes for patients with early SD, partial response (PR) or complete response (CR) with pembrolizumab. PATIENTS AND METHODS: Patients who received pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamid, Omid, Robert, Caroline, Daud, Adil, Carlino, Matteo S., Mitchell, Tara C., Hersey, Peter, Schachter, Jacob, Long, Georgina V., Hodi, F. Stephen, Wolchok, Jedd D., Arance, Ana, Jacques Grob, Jean, Joshua, Anthony M., Weber, Jeffrey S., Mortier, Laurent, Jensen, Erin, Diede, Scott J., Homet Moreno, Blanca, Ribas, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350885/
https://www.ncbi.nlm.nih.gov/pubmed/34571336
http://dx.doi.org/10.1016/j.ejca.2021.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350885/
https://www.ncbi.nlm.nih.gov/pubmed/34571336
http://dx.doi.org/10.1016/j.ejca.2021.08.013

Ejemplares similares